Anagrelide treatment in 52 patients with chronic myeloproliferative diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anagrelide treatment in 52 patients with chronic myeloproliferative diseases

Published:2004-10 Issue:5 Volume:26 Page:335-340
ISSN:0141-9854
Container-title:Clinical and Laboratory Haematology
language:en
Short-container-title:Clin Lab Haematol

Author:

Penninga E.,Jensen B. A.,Hansen P. B.,Clausen N. T.,Mourits-Andersen T.,Nielsen O. J.,Hasselbalch H. C.

Publisher

Wiley

Subject

Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine,Biochemistry (medical),Clinical Biochemistry,Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2257.2004.00637.x/fullpdf

Reference26 articles.

1. Anagrelide, a therapy for thrombocythemic states: Experience in 577 patients

2. Studies of platelet volume, chemistry and function in patients with essential thrombocythaemia treated with Anagrelide

3. Anagrelide-Induced Erectile Dysfunction

4. Role of Anagrelide in the Treatment of Thrombocytosis

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the “Ph1‐negative Myeloproliferative Neoplasms Latium Group”;European Journal of Haematology;2020-06-16

2. Comparison of starting doses of anagrelide as a first-line therapy in patients with cytoreductive therapy-naïve essential thrombocythemia: difference between starting at 0.5 and 1.0 mg/day;International Journal of Hematology;2020-04-23

3. Anagrelide;Meyler's Side Effects of Drugs;2016

4. Advances and challenges in the management of essential thrombocythemia;Therapeutic Advances in Hematology;2015-04-29

5. Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in F rance;European Journal of Haematology;2013-11-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3